<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00718276</url>
  </required_header>
  <id_info>
    <org_study_id>2007-09-13-HyD</org_study_id>
    <nct_id>NCT00718276</nct_id>
  </id_info>
  <brief_title>Pharmacokinetic Study: Effect of 25(OH)D and Vitamin D3 on Serum 25(OH)D</brief_title>
  <official_title>Pharmacokinetic Study in Healthy Postmenopausal Women to Compare Supplementation of Vitamin D3 to 25(OH)D</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Zurich</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Zurich</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      We compare the effect of HyD (25-hydroxyvitamin D) and vitamin D3 in their effect on
      25-hydroxyvitamin D plasma levels over a course of 4 month. This is a pharmacokinetic study
      including 35 postmenopausal women.

        -  Trial with medicinal product
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      We include postmenopausal women age 50 to 75, race/ethnicity: Caucasian, serum 25(OH)D at
      baseline between 20 to 60 nmol/l, body mass index: &lt; 30 kg/m2

      to compare 25(OH)D and vitamin D3 in equimolar doses over a 4 month pharmacokinetic trial.
      The dosing arms are daily, weekly, and bolus
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>March 2008</start_date>
  <completion_date type="Actual">September 2008</completion_date>
  <primary_completion_date type="Actual">August 2008</primary_completion_date>
  <phase>Phase 1</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>serum 25(OH)D levels</measure>
    <time_frame>repeated assessments over 4 months</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>muscle strength, blood pressure, blood glucose, bone markers</measure>
    <time_frame>repeated assessments over 4 months</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">35</enrollment>
  <condition>Healthy</condition>
  <arm_group>
    <arm_group_label>1</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>25(OH)D</description>
  </arm_group>
  <arm_group>
    <arm_group_label>2</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>vitamin D3</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>25(OH)D</intervention_name>
    <description>daily (20ug), weekly (140 ug), Bolus (140 ug)</description>
    <arm_group_label>1</arm_group_label>
    <other_name>HyD</other_name>
  </intervention>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>vitamin D3</intervention_name>
    <description>daily (800 IU), weekly (5600 IU), Bolus (5600 Iu)</description>
    <arm_group_label>2</arm_group_label>
    <other_name>Cholecalciferol</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion criteria:

          -  Postmenopausal women

          -  Age 50 to 75 years

          -  Body mass index 18-29 kg/m2

          -  25-hydroxyvitamin D levels 20 to 60 nmol/l

          -  Caucasian

          -  Generally healthy

        Exclusion criteria:

          -  Serum calcium &gt; 2.6 nmol/L

          -  Use if dietary supplements (&gt; 400 IU vitamin D per day, &gt; 600 mg of calcium per day)

          -  Hypertension

          -  Diseases that carry the risk of hypercalcemia

          -  Use of any drug that interferes with bone metabolism in the last 12 months
             (bisphosphonates estrogen receptor modulators, PTH, calcitonin)

          -  Oral HRT in the last 6 months

          -  Extreme diets

          -  Fracture or fall in the last 3 months

          -  Current smoking or alcohol abuse

          -  Planning on a sunny vacation in the course of the trial

          -  Kidney stone history

          -  Creatinine clearance &lt; 30 ml/min

          -  Co-medications: anticoagulants, PTH, corticosteroids, thiazide diuretics, digoxin,
             anticonvulsants, malabsorption,z C
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>50 Years</minimum_age>
    <maximum_age>75 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Heike Bischoff Ferrari, MD, MPH</last_name>
    <role>Principal Investigator</role>
    <affiliation>University Hospital Zurich, Centre on Aging and Mobility</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>University Hospital Zurich, Centre on Aging and Mobility</name>
      <address>
        <city>Zurich</city>
        <state>ZH</state>
        <zip>8091</zip>
        <country>Switzerland</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Switzerland</country>
  </location_countries>
  <verification_date>December 2011</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>July 17, 2008</study_first_submitted>
  <study_first_submitted_qc>July 17, 2008</study_first_submitted_qc>
  <study_first_posted type="Estimate">July 18, 2008</study_first_posted>
  <last_update_submitted>December 22, 2011</last_update_submitted>
  <last_update_submitted_qc>December 22, 2011</last_update_submitted_qc>
  <last_update_posted type="Estimate">December 23, 2011</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Healthy postmenopausal women</keyword>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Vitamins</mesh_term>
    <mesh_term>Vitamin D</mesh_term>
    <mesh_term>Ergocalciferols</mesh_term>
    <mesh_term>Cholecalciferol</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

